📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles. (2022)

First Author: Espejo-Román JM

Attributed to: The UK High-End Computing Consortium for Biomolecular Simulation funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics14040788

PubMed Identifier: 35456622

Publication URI: http://europepmc.org/abstract/MED/35456622

Type: Journal Article/Review

Volume: 14

Parent Publication: Pharmaceutics

Issue: 4

ISSN: 1999-4923